Age-related macular degeneration (AMD) is a progressive retinal disease that affects central vision. In its most advanced stage, known as end-stage AMD, patients lose the ability to see fine details in the center of their visual field.

Although peripheral vision often remains functional, the absence of central vision significantly reduces independence. Everyday activities such as reading, recognizing faces, and performing detailed visual tasks become extremely difficult or impossible without assistance.

CentraSight as a Comprehensive Treatment Approach

CentraSight is a structured clinical program developed for individuals with end-stage AMD and profound central vision loss. It is designed to improve functional vision through a combination of advanced surgical intervention and rehabilitation support.

The program is built around an implantable miniature telescope, but it also includes a complete care pathway that begins with patient evaluation and continues through post-surgical training and adaptation.

The Implantable Miniature Telescope Technology

The core of the CentraSight system is a tiny telescope implanted into one eye. During surgery, the eye’s natural lens is removed and replaced with this specialized optical device.

Once implanted, the telescope magnifies incoming visual images and redirects them onto healthier, unaffected areas of the retina. This enables the visual system to make use of remaining functional retinal tissue to process central detail more effectively.

The result is improved perception of central objects, while the non-implanted eye continues to support peripheral vision and spatial awareness.

Patient Screening and Eligibility Requirements

Before treatment, patients undergo a detailed diagnostic evaluation to determine whether they are suitable candidates for the procedure.

This process typically includes vision testing, retinal imaging, and a full assessment of eye health. The goal is to confirm that the level of vision loss is consistent with end-stage AMD and that the eye structure can safely support implantation.

In some cases, patients may also be introduced to visual simulation tools to help them understand the expected post-surgical experience.

Surgical Implantation Procedure

If a patient is deemed eligible, the implantation procedure is performed by a specialized ophthalmic surgeon. The surgery involves removing the natural lens of the eye and inserting the miniature telescope in its place.

The procedure is done on only one eye, ensuring that the second eye remains available for peripheral vision and general orientation.

After surgery, the eye requires a healing period before visual rehabilitation begins.

Post-Surgical Rehabilitation and Training

Rehabilitation is a critical part of the CentraSight program. Vision improvement does not occur automatically after surgery; patients must learn how to interpret their new visual input.

Through structured training with low-vision specialists, patients practice using the magnified central image for everyday tasks. This may include reading exercises, object identification, and mobility-related visual skills.

Over time, patients gradually adapt to the new visual system, allowing for improved functional independence.

Expected Outcomes and Limitations

CentraSight is not a cure for AMD and does not restore normal vision. Its primary goal is to enhance usable central vision and improve the patient’s ability to perform daily activities.

While many individuals experience meaningful improvements, results vary depending on the severity of the condition and the effectiveness of rehabilitation. Full restoration of vision and driving ability are not expected outcomes.

An Integrated Model of Eye Care

CentraSight centrasight.com represents a modern, multidisciplinary approach to vision rehabilitation. It combines surgical innovation with ongoing patient support to address both the medical and functional challenges of severe vision loss.

By integrating technology with rehabilitation, the program aims to help patients achieve greater independence and improved quality of life despite advanced AMD.